Employer coverage is still the access question behind obesity medicines

The access question around obesity medicines is often decided at work, not in a doctor’s office. Employers and health plans are still setting different rules for what they will cover and for whom.

Cost is a central reason, but a coverage policy is not a measure of medical need or of a medicine’s value for any one person. It is an administrative decision with uneven consequences across jobs and plans.

The evidence captures a moving system rather than a single national answer. Readers need the terms of their own plan, while the broader policy question remains how access will change as prices, evidence and benefit design change.

Read the full story at CNBC Health and Science ↗